BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31663577)

  • 1. Fenton-reaction-stimulative nanoparticles decorated with a reactive-oxygen-species (ROS)-responsive molecular switch for ROS amplification and triple negative breast cancer therapy.
    Zhang J; Zuo T; Liang X; Xu Y; Yang Y; Fang T; Li J; Chen D; Shen Q
    J Mater Chem B; 2019 Dec; 7(45):7141-7151. PubMed ID: 31663577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myricetin-induced apoptosis of triple-negative breast cancer cells is mediated by the iron-dependent generation of reactive oxygen species from hydrogen peroxide.
    Knickle A; Fernando W; Greenshields AL; Rupasinghe HPV; Hoskin DW
    Food Chem Toxicol; 2018 Aug; 118():154-167. PubMed ID: 29742465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles based on polymers modified with pH-sensitive molecular switch and low molecular weight heparin carrying Celastrol and ferrocene for breast cancer treatment.
    Qian Y; Zhang J; Xu R; Li Q; Shen Q; Zhu G
    Int J Biol Macromol; 2021 Jul; 183():2215-2226. PubMed ID: 34097964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of mitochondrial apoptotic pathway in triple negative breast carcinoma cells by methylglyoxal via generation of reactive oxygen species.
    Roy A; Ahir M; Bhattacharya S; Parida PK; Adhikary A; Jana K; Ray M
    Mol Carcinog; 2017 Sep; 56(9):2086-2103. PubMed ID: 28418078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ROS-responsive Galactosylated-nanoparticles with Doxorubicin Entrapment for Triple Negative Breast Cancer Therapy.
    Zhou J; Li K; Zang X; Xie Y; Song J; Chen X
    Int J Nanomedicine; 2023; 18():1381-1397. PubMed ID: 36987427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating metastatic triple negative breast cancer with CD44/neuropilin dual molecular targets of multifunctional nanoparticles.
    Liang DS; Zhang WJ; Wang AT; Su HT; Zhong HJ; Qi XR
    Biomaterials; 2017 Aug; 137():23-36. PubMed ID: 28528300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silver-coated zero-valent iron nanoparticles enhance cancer therapy in mice through lysosome-dependent dual programed cell death pathways: triggering simultaneous apoptosis and autophagy only in cancerous cells.
    Yang LX; Wu YN; Wang PW; Huang KJ; Su WC; Shieh DB
    J Mater Chem B; 2020 May; 8(18):4122-4131. PubMed ID: 32267258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting the proliferation, migration and invasion of triple negative breast cancer cells through anti-tumor human serum albumin nanoparticles loading aziditaxel as a novel taxane derivative.
    Chen LQ; Zhang ZM; Huang W; Gao ZG; Fang WS; Jin MJ; Yu L
    Pharmazie; 2017 Mar; 72(3):152-160. PubMed ID: 29442050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.
    Hong Y; Fan D
    Toxicology; 2019 Apr; 418():22-31. PubMed ID: 30797898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
    Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
    Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fe
    Chen T; Chu Q; Li M; Han G; Li X
    J Nanobiotechnology; 2021 Jul; 19(1):206. PubMed ID: 34246260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment.
    Hu G; Chun X; Wang Y; He Q; Gao H
    Oncotarget; 2015 Dec; 6(38):41258-74. PubMed ID: 26517810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Reactive Oxygen Species Levels by an Active Benzothiazole Complex-Mediated Fenton Reaction for Highly Effective Antitumor Therapy.
    You C; Wu H; Gao Z; Chen F; Ning L; Zhang Y; Dong Y; Sun B; Wang F
    Mol Pharm; 2019 Dec; 16(12):4929-4939. PubMed ID: 31661289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitroxide radical-containing nanoparticles attenuate tumorigenic potential of triple negative breast cancer.
    Shashni B; Nagasaki Y
    Biomaterials; 2018 Sep; 178():48-62. PubMed ID: 29908344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol loaded oxidized mesoporous carbon nanoparticles: A promising tool to treat triple negative breast cancer.
    Fan C; Kong F; Shetti D; Zhang B; Yang Y; Wei K
    Biochem Biophys Res Commun; 2019 Nov; 519(2):378-384. PubMed ID: 31519327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy.
    Song Y; Sun Y; Tang M; Yue Z; Ni J; Zhao J; Wang W; Sun T; Shi L; Wang L
    ACS Appl Mater Interfaces; 2022 Feb; 14(4):4914-4920. PubMed ID: 35050579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-Fenton Reactors as a New Class of Oxidative Stress Amplifying Anticancer Therapeutic Agents.
    Kwon B; Han E; Yang W; Cho W; Yoo W; Hwang J; Kwon BM; Lee D
    ACS Appl Mater Interfaces; 2016 Mar; 8(9):5887-97. PubMed ID: 26888039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer.
    Fang H; Gai Y; Wang S; Liu Q; Zhang X; Ye M; Tan J; Long Y; Wang K; Zhang Y; Lan X
    J Nanobiotechnology; 2021 Mar; 19(1):81. PubMed ID: 33743740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin.
    Cheng J; Zhu Y; Xing X; Xiao J; Chen H; Zhang H; Wang D; Zhang Y; Zhang G; Wu Z; Liu Y
    Theranostics; 2021; 11(11):5418-5429. PubMed ID: 33859755
    [No Abstract]   [Full Text] [Related]  

  • 20. Thioridazine hydrochloride: an antipsychotic agent that inhibits tumor growth and lung metastasis in triple-negative breast cancer via inducing G0/G1 arrest and apoptosis.
    Song Y; Li L; Chen J; Chen H; Cui B; Feng Y; Zhang P; Zhang Q; Xia Y; Luo M
    Cell Cycle; 2020 Dec; 19(24):3521-3533. PubMed ID: 33315498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.